Skip to main content
. 2025 Jul 1;16(10):3015–3023. doi: 10.7150/jca.113815

Table 2.

Response rate in unadjusted patients (i.e. all patients sample).

Category P n (%) P + CHT n (%)
CR 24 (4.2) 1 (1.4)
PR 233 (40.4) 51 (72.9)
SD 198 (34.4) 11 (15.7)
PD 121 (21.0) 7 (10.0)
Unknown 130 17

CR = complete response; P = pembrolizumab; P + CHT = pembrolizumab + chemotherapy; PD = progressive disease; PR = partial response; SD = stable disease